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Soluble Uric Acid Activates the 
NLRP3 Inflammasome
Tarcio Teodoro Braga1,2, Maria Fernanda Forni3, Matheus Correa-Costa1, 
Rodrigo Nalio Ramos4, Jose Alexandre Barbuto4, Paola Branco5, Angela Castoldi1, 
Meire Ioshie Hiyane1, Mariana Rodrigues Davanso2, Eicke Latz2,6,7,8, Bernardo S. Franklin2,*, 
Alicia J. Kowaltowski3,* & Niels Olsen Saraiva Camara1,9,10,*
Uric acid is a damage-associated molecular pattern (DAMP), released from ischemic tissues and dying 
cells which, when crystalized, is able to activate the NLRP3 inflammasome. Soluble uric acid (sUA) is 
found in high concentrations in the serum of great apes, and even higher in some diseases, before the 
appearance of crystals. In the present study, we sought to investigate whether uric acid, in the soluble 
form, could also activate the NLRP3 inflammasome and induce the production of IL-1β. We monitored 
ROS, mitochondrial area and respiratory parameters from macrophages following sUA stimulus. 
We observed that sUA is released in a hypoxic environment and is able to induce IL-1β release. This 
process is followed by production of mitochondrial ROS, ASC speck formation and caspase-1 activation. 
Nlrp3−/− macrophages presented a protected redox state, increased maximum and reserve oxygen 
consumption ratio (OCR) and higher VDAC protein levels when compared to WT and Myd88−/− cells. 
Using a disease model characterized by increased sUA levels, we observed a correlation between sUA, 
inflammasome activation and fibrosis. These findings suggest sUA activates the NLRP3 inflammasome. 
We propose that future therapeutic strategies for renal fibrosis should include strategies that block sUA 
or inhibit its recognition by phagocytes.
Uric acid, the product of purine catabolism, is a damage-associated molecular pattern (DAMP) released from 
ischemic tissues and dying cells1,2. Once crystalized, uric acid activates the immune system3,4, since it acts as a 
pro-oxidant molecule that reduces nitric oxide availability1, increases the production of reactive oxygen species 
(ROS), stimulates chemotaxis and also activates NF-κ B and MAPK pathways1. Uric acid crystals also induce the 
release of proinflammatory cytokines such as IL-1β 4,5, a signaling molecule secreted when the formation of a high 
molecular weight complex named “inflammasome” is activated6.
Crystals trigger inflammasome activation4,7–9 mainly through frustrated phagocytosis, a process character-
ized either by aberrant actin polymerization10 or by lysosomal damage11, in which lysosome contents leak into 
the cytosol. Lysosomal proteases, once in the cytosol, in addition to acting as DAMPs12, are able to digest vital 
proteins and affect other organelles, such as the mitochondria. In addition, uric acid crystals can directly engage 
cellular membranes without the involvement of any known cellular receptor. Recent evidences demonstrate that 
serum uric acid levels are also associated with inflammatory effects, such as in gout-related disease and preec-
lampsia13,14. However, it is still unknown if soluble uric acid (sUA) activates the inflammasome complex and lead 
to IL-1β production. Primates lost the uricase gene and the direct consequence is that they have higher serum 
uric acid levels than other animals15. The mutation in the uricase gene that occurred during food scarcity and 
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global cooling resulted in a survival advantage at that time16. Today, however, it is associated with hypertension, 
kidney disease, obesity and diabetes17. Accumulating evidence has revealed a positive relationship between serum 
uric acid levels and cardiovascular mortality in patients with chronic kidney disease18,19. Despite an unknown 
mechanism, local accumulation of uric acid may activate the inflammasome complex, leading to inflammation 
and fibrosis20.
The most studied inflammasome sensor is the NACHT, LRR, and PYD domain-containing protein 3 (NLRP3), 
a protein that interacts with the adapter molecule, ASC, which in turn interacts with pro-caspase-121,22. A specific 
gain-of-function mutation in the Nlrp3 gene is a marker of auto inflammatory disorders23,24. In affected patients, 
mutations in Nlrp3 lead to a spontaneous release of IL-1β 25. NLRP3 activation has been shown to play impor-
tant roles in many auto inflammatory26,27, metabolic28–30 and neurodegenerative diseases31,32. ROS production in 
macrophages triggers the NLRP3 inflammasome9,33, but the cellular compartment from which ROS originates 
remains controversial34. The main source of a diverse variety of ROS in most cells is mitochondria35,36, in which 
a large number of oxidant-generating reactions exist37. ROS act as signaling molecules and regulate metabolism, 
proliferation38 and inflammation, as indicated by the fact that either deficiency in NADPH oxidase (an enzymatic 
ROS source) or the presence of antioxidants inhibit NLRP3 inflammasome activation9. In addition to ROS pro-
duction, mitochondria orchestrate NLRP3 inflammasome activation through mechanisms involving changes in 
mitochondrial DNA39, membrane lipids40 and ion flux41, among others42.
In the present study, we investigated whether uric acid could induce the production of IL-1β in its soluble 
form. We hypothesized that sUA is able to activate the NLRP3 inflammasome. We monitored ROS production, 
modifications in mitochondrial area and respiratory parameters from macrophages following sUA stimulus and 
observed that sUA is released in a hypoxic environment and, when the first signal of inflammasome activation 
is present, is able to trigger NLRP3 through the production of mitochondrial ROS. This process is followed by 
ASC speck formation, caspase-1 activation and IL-1β production. We took advantage of a fibrotic disease model 
in which increased levels of sUA occur, and observed a correlation between tissue damage and the degree of sUA 
formation. Indeed, we demonstrate that macrophages derived from Nlrp3 deficient mice, when compared to WT 
and Myd88 deficient animals, present protected redox state, increased maximum and reserve oxygen consump-
tion rates (OCR), and higher VDAC protein levels.
Results
Soluble Uric Acid Activates the NLRP3 Inflammasome. We incubated bone marrow-derived mac-
rophages in the presence of soluble uric acid alone (sUA) and/or LPS (sUA+ LPS) for 6, 24 or 72 hours. We 
observed that SUA+ LPS induced IL-1β mRNA expression when compared to non-stimulated cells and to cells 
stimulated with either sUA, or LPS alone. IL-1β expression was higher at 6 h and decreased with time (Fig. 1a). 
Cleaved IL-1β levels were enhanced in the supernatant after SUA+ LPS stimulation for 24 h (Fig. 1b). We also 
observed that inflammasome activation by sUA+ LPS is NLRP3- and MyD88-dependent, since macrophages 
from Nlrp3−/− and Myd88−/− mice failed to produce IL-1β levels comparable to Wild-type mice (WT) (Fig. 1c). 
Moreover, as shown in Supplementary Fig. 1 A, sUA stimulates IL-1β production in a dose-dependent way and 
the cytokine levels are lower than that observed after monosodium urate (MSU) crystals stimulus. Macrophages 
with a gain of function of Nlrp3 under a lysozyme (LyzCreNlrp3flox) or integrin alpha X (ItgaxCreNlrp3flox) pro-
moter presented increased levels of IL-1β after sUA+ LPS stimulus when compared to WT macrophages (Fig. 1d). 
Inflammasome activation with sUA+ LPS was further confirmed through the measurement of the proteolytic 
activity of caspase-1. We observed reduced caspase-1 activity in Nlrp3−/− and Myd88−/− macrophages when 
compared to WT (Fig. 1e). To confirm that IL-1β production was due to the presence of uric acid promoted by 
LPS, we added uricase (UC) into WT macrophage cultures right before stimulating them with sUA+ LPS. The 
decreased levels of IL-1β protein (Fig. 1c) and decreased caspase-1 activity (Fig. 1e) observed confirm that uric 
acid is responsible for these effects. Like many other inflammasome activators, sUA+ LPS stimulation results in 
pyroptosis, as measured by the release of lactate dehydrogenase (LDH) (Fig. 1f). sUA also induced the polymeri-
zation of the adaptor molecule ASC and the assembly of ASC specks when added in the presence of LPS (Fig. 1g). 
Moreover, we confirmed that the ASC speck formation observed was not due to the presence of crystals in the 
sUA preparations, which can be observed after MSU stimulation in the presence of LPS (Fig. 1h). Indeed, neither 
phagocytosis inhibition by cytochalasin D (Sup. Fig. 1B) nor blockage of vacuolar H+ ATPase system by bafilom-
icn A (Sup. Fig. 1C) did not lead to decreased IL-1β production by sUA, in opposite to IL-1β production by MSU 
crystals. Together, these findings identified sUA as a factor able to trigger the NLRP3 inflammasome.
sUA is released following cell death, especially when hypoxic conditions deprive tissues of energy43. In an 
attempt to find the possible source of sUA, we subjected WT macrophages to hypoxic conditions. Hypoxia 
induced uric acid release (Sup. Fig. 1D) and increased the expression of IL-1β (about 6 fold), Myd88 (about 5 fold) 
and Naip1 (about 15 fold), mRNA (Sup. Fig. 1E) by these cells. Hypoxia was reported to reduce mRNA expression 
of some inflammasome-regulating molecules such as Nlrp1244 and Nlrp445. Accordingly, we found that hypoxia 
led to IL-1β protein production, a process that can be reversed by uricase treatment (Sup. Fig. 1F). On the other 
hand, in the absence of either Nlrp3 or Myd88, hypoxic conditions did not lead to IL-1β production (Sup. Fig. 1F).
Differently from other mammals, including mice, humans have lost the capacity to synthesize uricase15. For this 
reason, humans possess tenfold higher concentrations of serum UA than mice (180–400 μ Μ versus 18–40 μ Μ )46,47. 
We then measured IL-1β production by macrophages derived from human monocytes in response to sUA. As 
shown in supplemental Fig. 1G and 1H, sUA, at a concentration that induces murine IL-1β , in the presence of 
LPS, there was no production of this cytokine in the supernatant and cell lysate of human macrophages. Indeed, 
sUA led to reduced LPS-induced TNFα production and increased IL10 production (Sup. Fig. 1H). Despite the 
consensus that UA released as a result of cell death in both species acts as an inflammatory trigger3,4, it is possible 
that pathological concentrations found in mice could not induce an immune response in human cells. These data 
www.nature.com/scientificreports/
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Figure 1. Soluble uric acid stimulates IL-1β production in a NLRP3- and MyD88-dependent way. 
Bone marrow-derived macrophages were stimulated with sUA (180 μ Μ ) and LPS (10 η g/mL). Non-
stimulated macrophages were used as controls and uricase (1 U/mL) and nigericin (10 μ Μ ) were used in 
some experiments. (a) il-1β mRNA was analyzed at different time points. (b) Western blotting of IL-1β and 
caspase-1 of cell supernatants after 24 hours stimulus. (c) Elisa of IL-1β of supernatants of WT, NLRP3−/− 
and MyD88−/− macrophages after different stimuli for 24 h. (d) Elisa of IL-1β was analyzed in supernatants 
of WT, ItgaxCreNLRP3flox and LyZCreNLRP3flox macrophages after sUA+ LPS stimulation for 24 h. (e) WT, 
NLRP3−/− and MyD88−/− macrophages were transfected with a luciferase-based inflammasome and protease 
activity reporter for proteolytic activity of caspase-1 (iGLuc). Luciferase activity was assessed 96 h after the 
indicated stimulus in the cellular supernatants. (f) Release of lactate dehydrogenase (LDH) into supernatants 
was measured at 24 hours and shown as percentage of maximum at each stimulus. (g) Immortalized ASC-
mCerulean macrophages were cultivated for 24 hours with indicated stimulus and ASC specks are represented 
as number of specks per ten microscopy fields. (h) Representative confocal photomicrographs of ASC-
mCerulean macrophages showing ASC specks (green) produced after the activation of inflammasomes. The 
plasmatic membrane is indicated in red, the nucleus in blue and crystals are shown by white arrows. In (a), 
qPCR data were normalized to HPRT expression, and the mean of the control condition was considered 1. 
In (b), the blots are cropped in order to improve the clarity and conciseness of the membrane presentation. 
In (e), r.l.u. indicates relative light units. In (h), the white bars represent 50 μ m. Data are representative of two 
independent experiments. n = 2 to 9. *p < 0.05; **p < 0.01; and ***p < 0.001. Nig = Nigericin; UC = uricase.
www.nature.com/scientificreports/
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indicate that 180 μ Μ sUA, rather than displaying inflammatory properties, may present an anti-inflammatory 
activity in human macrophages.
Soluble Uric Acid Triggers the Inflammasome and Leads to Tissue Damage. In order to investi-
gate the role of sUA in vivo, we used an obstructive nephropathy model, unilateral ureter obstruction (UUO), 
which causes renal fibrosis and inflammation48. We observed increased hypoxic areas in obstructed kidneys 
when compared with sham kidneys (Fig. 2a and b). The energy-deprived state observed in hypoxic conditions 
can be compensated by the degradation of certain molecules containing high-energy phosphate bonds, lead-
ing to increased levels of adenosine, which is subsequently degraded to hypoxanthine, xanthine, and ultimately 
uric acid49. Indeed, we observed an increase in xanthine dehydrogenase (XDH) mRNA expression, the enzyme 
responsible for transforming purine bases into uric acid50 (Fig. 2c). We also observed increased levels of kidneys 
sUA 7 days post-obstruction (Fig. 2d). The mRNA levels of inflammasome-related cytokines, such as Il-1β, Il33, 
Nlrp3 and Myd88 were also increased in the kidneys 7 days after surgery (Fig. 2e). The hydrostatic pressure 
ensuing from kidney obstruction can trigger interstitial inflammatory infiltration, indicated mainly by increased 
numbers of tissue infiltrating-macrophages48,51. This process contributes toward progressive fibrosis with loss of 
renal parenchyma and extracellular matrix (ECM) deposition52. We therefore observed that deficiency in Myd88, 
Nlrp3, Casp1, or Il1r reduced both collagen deposition (Fig. 2f and g) and proteinuria in obstructed pelvises 
(Fig. 2h) when compared to WT mice.
In an attempt to reverse the fibrotic scenario seen in WT mice submitted to UUO, we administrated allopu-
rinol (Allop), a XDH inhibitor. Allopurinol treatment reduced tissue levels of uric acid (Fig. 3a) and proteinuria 
in treated UUO mice (Fig. 3b). These mice also displayed decreased type 1 collagen mRNA levels (Fig. 3c) and less 
hydroxyproline (Fig. 3d), the main amino acid that forms collagen. The mRNA expression of Il-1β, Il33, Nlrp3, 
inos and Myd88 (Fig. 3e) was also reduced, as well as IL-1β protein (Fig. 3f) in allopurinol treated UUO mice, 
compared to those not treated. Finally, we injected uric acid into WT, Myd88−/− and Nlrp3−/− mice submitted to 
UUO. The injection led to increased protein levels in the urine of obstructed pelvises in WT animals (Fig. 3g). 
In contrast, proteinuria was not increased in sUA injected-Myd88−/− and Nlrp3−/−. Indeed, uric acid injection 
increased mRNA expression of type 1 collagen in WT and Myd88−/−, but not in Nlrp3−/− mice (Fig. 3h). In turn, 
analysis of collagen deposition by sirius red staining demonstrated that uric acid injection led to increased col-
lagen deposition in WT, but not in Myd88−/− and Nlrp3−/− mice (Fig. 3i). Altogether, our data demonstrate that 
sUA, released in the context of ureteral obstruction, is responsible for triggering inflammation and for consequent 
induction of fibrosis, in a Myd88- and Nlrp3- dependent manner.
Soluble Uric Acid Triggers the NLRP3 Inflammasome in a Mitochondrial ROS-Dependent 
Manner. In an attempt to address the mechanisms by which sUA promotes NLRP3 inflammasome activa-
tion, we analyzed mitochondrial ROS production by staining cells with the mitochondrial-targeting fluorescent 
probe MitoSOX53. Oxidation of MitoSOX Red produces red fluorescence. Contrary to sUA+ LPS treated WT and 
Myd88−/−, Nlrp3−/− macrophages did not display an increase in mitochondrial fluorescence (Fig. 4a and b). We 
also determined the levels of different forms of glutathione, a ubiquitous thiol-containing tripeptide, implicated 
in cellular antioxidant defense, which is widely used as a reductant and redox state marker54. Relative GSH/GSSG 
ratios were mostly unchanged in non-stimulated cells except for the Nlrp3−/− cells that presented increased ratios 
(Fig. 4c). After 24 h stimulation with sUA+ LPS, WT, Myd88−/− and Nlrp3−/− macrophages decreased the ratios 
of GSH to GSSG. In Nlrp3−/− cells, however, the ratio of GSH/GSSG decreased to a much lesser extent (Fig. 4c), 
suggesting a more reduced intracellular environment even after stimulation.
N-acetyl-l-cysteine (NAC), a reductant, inhibits NLRP3 activation in different models55–57. Likewise, we 
observed that NAC decreased MitoSOX fluorescence in WT macrophages after a 6 h stimulation with sUA+ 
LPS (Fig. 4d and e). Also, NAC decreased IL-1β levels (Fig. 4f). Altogether, these data suggest that sUA triggers 
ROS generation only in the presence of Nlrp3, a condition in which the cells present a non-protective redox state. 
Moreover, treatment with NAC diminished inflammasome activation and consequently, IL-1β production.
In addition to mitochondrial ROS, several inflammasome triggers have been described58,59. We observed that 
sUA also activates the NLRP3 inflammasome through ion flux, specifically via potassium efflux, since the inhi-
bition of cellular K+ removal in WT macrophages also inhibited IL-1β production (Sup. Fig. 2A). Indeed, sUA+ 
LPS changed the morphology of WT macrophages after 24 h, especially the shape of the plasma membrane (Sup. 
Fig. 2B). This was not observed in macrophages from Myd88−/−, Nlrp3−/− mice. These data indicate that sUA may 
trigger the NLRP3 inflammasome in different but complementary manners, such as inducing mitochondrial ROS 
production, potassium efflux and through changes in cell membrane morphology.
Soluble Uric Acid Alters Mitochondrial Components. Given the observed changes in mitochondrial 
redox state, we searched for other functional mitochondrial modifications after sUA+ LPS stimulation. sUA+ 
LPS was able to increase mitochondrial area after 24 h in both WT and Myd88−/− cells, a process reverted by the 
addition of uricase (Fig. 4g and h), and suggestive of enhanced mitochondrial biogenesis. There was, however, no 
increase in mitochondrial area when Nlrp3−/− macrophages were exposed to sUA+ LPS.
We attempted next to uncover possible changes in mitochondrial respiration after stimulus with sUA in the 
presence of LPS by measuring oxygen consumption rates (OCR) of WT, Myd88−/−, and Nlrp3−/− macrophages. 
Figure 5a show typical OCR traces, and indicate that Nlrp3−/− macrophages present increased basal oxygen con-
sumption (the OCR before 30 min) when compared to WT, or Myd88−/− cells. sUA+ LPS stimulation did not 
alter basal OCR (Fig. 5b, upper graph). The addition of oligomycin, an inhibitor of mitochondrial ATP synthesis, 
allowed us to analyze ATP-linked respiration and the proton leak across the inner membrane (Fig. 5b, middle 
and lower graphs). No differences in ATP-linked oxygen consumption after stimulus with sUA in the presence of 
LPS were observed, despite the higher ATP-linked OCR in Nlrp3−/− macrophages (Fig. 5b, middle graph). On the 
www.nature.com/scientificreports/
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Figure 2. Soluble uric acid triggers the inflammasome and is responsible for renal damage. WT, MyD88−/−, 
NLRP3−/−, Casp1−/− and IL1R−/− animals were submitted to ureteral obstruction and renal damage was 
investigated seven days later. (a) Quantitative analysis of the hypoxic area, represented by the proportion of the 
pimonidazole staining area compared to the total area of the field and (b) representative photomicrographs of 
pimonidazole uptake. (c) XDH mRNA, (d) sUA and (e) inflammasome-related genes in the kidney tissue of 
WT mice submitted to UUO and sham ones. (f) Proteinuria in the urine of obstructed pelvises normalized to 
that in the urine of the animals before surgery. (g) Representative photomicrographs and (h) quantification of 
collagen deposition, as analyzed by Sirius red staining, in the kidneys of WT, Casp1−/−, IL1R−/−, NLRP3−/− 
and MyD88−/− mice. In (a and f), the bars represent 50 μ m in all photomicrographs. Sirius red staining and 
pimonidazole deposition are represented by the percentage of stained area out of the total area in the field. 
qPCR data were normalized to HPRT expression, and the mean expression in sham mice was considered 1.  
n = 3 to 13 animals per group in each experiment. *p < 0.05; **p < 0.01; and ***p < 0.001.
www.nature.com/scientificreports/
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other hand, sUA+ LPS increased the proton leak in all analyzed macrophages (Fig. 5b, lower graph). Additionally, 
maximal respiratory rates and reserve capacity, measured in the presence of the mitochondrial uncoupler CCCP, 
were larger after sUA+ LPS stimulus in Nlrp3 deficiency, but not in Myd88−/− and WT macrophages (Fig. 5c, 
upper and middle graphs). The non-mitochondrial OCR was uncovered using rotenone to inhibit Complex I 
and antimycin A to inhibit Complex III60. We observed that sUA+ LPS increased non-mitochondrial respiration 
in all analyzed macrophages (Fig. 5c, lower graph). Overall, our data demonstrate that among all macrophages 
analyzed, only Nlrp3−/− cells increased maximal and reserve OCR under sUA+ LPS stimulus. We next increased 
the maximal OCR of WT macrophages by using CCCP at low doses (Sup. Fig. S3A–C). We observed no dif-
ferences in IL-1β production from WT macrophages stimulated with sUA+ LPS treated or not with of CCCP 
(Sup. Fig. S3D and E). Our data suggests the responsiveness to sUA is not directly dependent on mitochondrial 
oxygen consumption rates.
Figure 3. Soluble uric acid is responsible for damage in obstructive nephropathy. Mice were either treated 
with allopurinol or injected with sUA following ureteral obstruction. (a–f) Allopurinol (Alop) treatment in WT 
mice. (a) Soluble tissue uric acid levels normalized by tissue protein. (b) Proteinuria in the urine of obstructed 
pelvises, normalized to that in the urine of the animals before surgery. (c) Type 1 collagen mRNA levels and 
(d) hydroxyproline levels normalized by tissue protein. (e) Inflammasome-related genes and (f) Elisa of IL-1β 
in obstructed kidneys. (g–i) SUA injection into WT, NLRP3−/− and MyD88−/− mice. (g) Proteinuria in the 
urine of obstructed pelvises, normalized to that in the urine of the animals before surgery. (h) Type 1 collagen 
mRNA levels and (i) quantification of collagen deposition, as analyzed by Sirius red staining. Sirius red staining 
deposition is represented by the percentage of stained area out of the total area in the field. qPCR data were 
normalized to HPRT expression, and the mean expression in sham mice was considered 1. n = 3 to 15 animals 
per group in each experiment. *p < 0.05.
www.nature.com/scientificreports/
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Figure 4. Soluble uric acid triggers the NLRP3 inflammasome and mitochondrial ROS production. WT, 
NLRP3−/− and MyD88−/− bone marrow-derived macrophages were stimulated with sUA in the presence of 
LPS (sUA+ LPS) and non-stimulated macrophages were used as controls. (a) Representative flow cytometry 
graphs and (b) quantification of MitoSox staining in cells under SUA+ LPS stimulus or control conditions 
for 24 h. (c) Relative reduced over oxidized glutathione (GSH/GSSG), normalized to total glutathione in WT 
macrophages under SUA+ LPS stimulus or control ones for 24 h. (d) Representative flow cytometry graphs and 
(e) quantification of MitoSox staining in WT macrophages in the presence or absence of N-acetyl-l-cysteine 
(NAC) under SUA+ LPS stimulus for 6 h. (f) Elisa of IL-1β in supernatants of macrophages analyzed as in (d) and 
(e) after 24 h of stimuli. (g) Transmission electronic photomicrographs of macrophages under different stimuli. 
Arrows point to mitochondria. The sUA+ LPS representative figures are increased by 5000X and the other two 
figures are increased by 7000X. (h) Quantification of mitochondrial area seen in (g). Data are representative of 
two independent experiments. n = 2 to 11 *p < 0.05; **p < 0.01; and ***p < 0.001. UC = uricase.
www.nature.com/scientificreports/
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Figure 5. Soluble uric acid promotes mitochondrial modifications in the absence of NLRP3. Bioenergetic 
profiles of bone marrow-derived macrophages in the presence or absence of sUA+ LPS. (a) Cells (60,000 
per well) were treated with respiratory inhibitors and uncoupler at the following concentrations: oligomycin 
(1 μgmL), CCCP (5 μ Μ ) and antimycin A (10 μ g/mL) plus rotenone (1 μ Μ ). (a) Representative oxygen 
consumption rates (OCR) from WT, NLRP3−/− and MyD88−/− macrophages. Gray lines represent sUA+ LPS 
stimulated cells and black lines represent control ones. (b, upper graph) Basal OCR (OCR before addition of 
inhibitors), (b, middle graph) ATP production-dependent OCR (basal OCR minus oligomycin-insensitive-
OCR), (b, lower graph) H+ leak (oligomycin-insensitive-OCR), (c, upper graph) maximal OCR (highest OCR 
after CCCP addition), (c, middle graph) reserve respiratory capacity (maximal OCR minus basal OCR), and 
(c, lower graph) non-mitochondrial respiration (OCR values in the presence of antimycin A plus rotenone) 
calculated from experiments such as those depicted in Panel a–c. (d) mRNA analysis of mitochondrial 
membrane component-related genes in different macrophages under sUA+ LPS stimulus and non-stimulated 
conditions. (e) VDAC mRNA expression and (f) western blotting of VDAC. In (a–c), data are representative 
of three independent experiments and n = 3 to 10. In (d), n = 10 in one experiment. In (e–f), data are 
representative of two independent experiments and n = 2 to 4. In (f), the blots are cropped in order to improve 
the clarity and conciseness of the membrane presentation. *p < 0.05; **p < 0.01; and ***p < 0.001.
www.nature.com/scientificreports/
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Due to the observed changes in mitochondrial function, we searched for differential expression of mito-
chondrial membrane component-related genes (Fig. 5d). Since redox changes can alter protein turnover61,62, we 
focused on ubiquitin c (Ubc) and observed an upregulation of Ubc mRNA levels only in WT and Myd88−/− 
macrophages after stimulation with sUA in the presence of LPS. Indeed, WT and Myd88−/−, but not Nlrp3−/− 
macrophages, presented increased tricarboxylate transport protein (Slc25a1) mRNA, a citrate carrier protein 
necessary for the generation of mitochondrial oxidative stress upon uric acid stimulation63,64 (Fig. 5d). We also 
investigated the mRNA expression of some outer mitochondrial membrane proteins after sUA+ LPS stimu-
lus. Mitofusin-2 (Mfn2)65–67 and Bcl-2-like protein 1 (Bcl2l1)68 mRNA levels did not increase in Nlrp3−/− cells. 
Indeed, the translocator protein (Tspo), a protein that binds to the voltage-dependent anion channel (VDAC) 
and interferes with redox balance69–71 was upregulated after sUA+ LPS stimulus in all macrophages analyzed, 
but in a more pronounced way in WT and Myd88−/− cells. Ultimately, VDAC, a protein involved in the transport 
of ATP, calcium and other metabolites across the mitochondrial outer membrane72,73, and related to integrity of 
this organelle in the context of NLRP3 activation74, was upregulated in Nlrp3−/− macrophages upon sUA+ LPS 
(Fig. 5e). Consistently, protein expression analyses demonstrated that sUA+ LPS stimulus led to reduced VDAC 
expression in WT and Myd88−/− macrophages, while Nlrp3−/− macrophages displayed similar levels of VDAC 
protein to non-stimulated cells (Fig. 5f). A set of differentially expressed mitochondrial components is shown 
(Sup. Fig. S4). It is predicted that Nlrp3 deficiency promotes changes in mitochondrial dynamics, a feature that 
has been proposed to be important under stressful conditions, especially under inflammasome activation.
Discussion
The study of uric acid reveals an intriguing aspect of evolution. Great Apes lost the uricase gene, a loss that may 
be related to a survival advantage16, giving rise to high-energy storage ability75. It is also accepted that, in some 
contexts, uric acid is a major antioxidant that protects cardiac, vascular, and neural cells from oxidative injury76,77. 
However, hyperuricemia, even without crystal deposition13, is strongly associated with disorders such as kidney 
disease, and hypertension78. A common pathogenic feature for all of these disorders is, paradoxically, the involve-
ment of redox imbalance79–81. We evaluated the role of soluble uric acid and found that it displays an inflamma-
tory role in murine cells. We, therefore, do not discard the hypothesis that the observed effects could be caused 
by microcrystals of uric acid, non-visualized by laser scanning confocal microscopy combined with reflection 
microscopy7 or polarizing microscopy82. Accordingly, the role of sUA was confirmed using an in vitro assay in 
which we demonstrated that sUA stimulated the dose- and time-dependent production of inflammasome-related 
molecules in the presence of Nlrp3 and Myd88. We confirmed our results using a model of renal disease in which 
we observed increased levels of sUA in the absence of crystals.
Elevated serum uric acid is associated with an increased prevalence of chronic kidney disease (CKD)83. The 
end stage of CKD, renal fibrosis, is the result of an injury that leads to the production of ECM components. 
Once this production is continuous, ECM deposition becomes massive and, associated with the uncontrolled 
apoptosis of tubular cells, results in tubular atrophy84. Matrix remodeling and cellular stress result in the release 
of molecules that ultimately activate an inflammatory response through innate-sensing receptors85–87. Until 
now, it was unclear how these innate immune receptors relate to fibrosis. We hypothesized that this connection 
involves inflammasome signaling. We observed that renal damage seen in UUO is dependent on NLRP3, MyD88, 
caspase-1 and IL-1 receptor. Additionally, we confirmed that uric acid is released after hypoxic conditions88, 
observed, for instance, after UUO, a model of urinary flow obstruction89,90. Indeed, increased sUA release cor-
related with increased kidney damage at seven days post UUO. Ultimately, inflammasome activation and IL-1β 
production lead to extracellular matrix deposition and kidney fibrosis91,92.
Two signals are required for inflammasome activation: the first signal, mediated by TLR, must be capable of 
inducing increased expression of pro-IL-1β ; the second signal would be responsible for cleavage of pro-IL-1β 
in its active form21. There are several hypotheses for the second signal activation and further investigations are 
necessary in order to find whether is there any common component for all second signals described, for example, 
the release of ROS93. We propose that the mechanism underlying sUA-induced inflammation is dependent on 
redox state changes and mitochondrial ROS production, in accordance with data demonstrating that high con-
centrations on uric acid may induce oxidative stress94. We observed that Nlrp3−/− macrophages present an intrin-
sically protective redox state and this could be the reason why macrophages did not produce ROS after sUA+ 
LPS stimulus. Nlrp3−/− macrophages also presented higher maximal and reserve oxygen consumption rates when 
compared to Myd88−/− and WT cells, which can be explained by the fact that ROS, chronically, lead to reduction 
in maximal and reserve capacity95. The increase in maximal oxygen consumption rates after CCCP stimulation 
for 24 hours at low doses, however, was not sufficient to prevent IL-1β production in WT macrophages. It seems 
that the decreased inflammasome activation is related to mitochondrial changes, but not to the increase in max-
imal oxygen consumption rates. Among the changes that mitochondria can undergo, organelle dysfunction has 
been demonstrated to be an NLRP3 inflammasome activator96. Indeed, mitochondria have multiple mechanisms 
that allow them to activate signaling pathways in the cytosol including altering in AMP/ATP ratios, the release 
of TCA cycle metabolites, as well as the localization of immune regulatory proteins to the outer mitochondrial 
membrane42.
Nlrp3−/− macrophages did not show changes in the expression of some mitochondrial membrane 
compound-related genes. On the other hand, VDAC mRNA increased after sUA+ LPS stimulus in Nlrp3−/−, but 
not in WT or Myd88−/− macrophages. VDAC, a protein related to the NLRP3 inflammasome74, is known to reg-
ulate mitochondrial ROS production97. The large number of cysteines in VDAC is believed to confer protection 
from ROS build-up in mitochondria72. It could be possible that Nlrp3 deficiency prevent cell response to sUA by 
removing the ability to produce ROS under stimulation. However, new studies are needed to better evaluate the 
flux of ions and ROS through mitochondrial membranes and the potential of mitochondrial membrane in the 
context of Nlrp3 deficiency, under different inflammasome stimuli.
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Altogether, our results provide evidence that uric acid, in its soluble form, is responsible for increasing IL-1β 
production in an Nlrp3- and Myd88-dependent manner. The NLRP3 inflammasome stimulation by sUA is 
accompanied by cellular redox state changes, increasing in mitochondria area and mitochondrial ROS produc-
tion. The observation that inflammasome activation can be triggered by sUA may have profound implications for 
fibrotic-related diseases. We propose that future therapeutic strategies for renal fibrosis, for instance, should be 
based on blocking sUA or inhibiting its recognition by phagocytes.
Material and Methods
Animal studies. LyzCreNlrp3flox or ItgaxCreNlrp3flox animals were generated by crossing LyzCre or ItgaxCre mice 
with Nlrp3flox/flox mice. Male Myd88−/−, Nlrp3−/−, Casp1−/−, Il1r−/−, LyzCreNlrp3flox or ItgaxCreNlrp3flox animals and 
control C57Bl/6 mice, aged 6 to 8 weeks, were bred and housed in a pathogen-free facility at the University of São 
Paulo. On day 0, unilateral ureteral obstruction (UUO) was performed by complete ligation of the right ureter. 
Seven days later, mice were sacrificed for biochemical, histological, protein and genetic analyses. Allopurinol 
(Schein Pharmaceutical, Florham Park, NJ, USA) was administered in the drinking water at 13 mg/dL to one 
cohort from day 0 until day 7. Uric acid (120 mg/kg i.p.) was injected intraperitoneally on day 0. All procedures 
were approved by the local ethics committees at the University of São Paulo (Document 45/2009). All experi-
ments were performed in accordance with relevant guidelines and regulations.
Soluble uric acid preparation. In experiments requiring soluble uric acid, media was pre-warmed (37 °C), 
and uric acid (Ultrapure, Sigma; 180 μ Μ ) was added. The mixture was warmed again (37 °C, 30 minutes) and 
sterilized through 0.20 μ m filters. Crystals were not detectable under these conditions (polarizing microscopy), 
nor did they develop during cell incubation.
Murine cells. Bone-marrow derived macrophages (BMDMs) were obtained by culturing bone marrow cells 
from 6- to 8-week old mice in DMEM supplemented with 20% L929-derived medium and 10% FBS. Seven days 
later, BMDMs were collected and plated. The inflammasome reporter macrophage stably transduced with con-
structs for the expression of mCerulean-tagged ASC has been described previously98.
Differentiation of human monocyte-derived macrophages in vitro. Human peripheral blood 
mononuclear cells (PBMCs) were obtained by a centrifugation gradient in Ficoll-Paque (Dominique Dutscher). 
Subsequently, PBMCs were centrifuged in 51% PBS-diluted Percoll (GE Healthcare Life Sciences) and monocytes 
(> 70% purity) were adhered in six well plates during 2 hours. After removal of non-adherent cells by washing the 
plates, monocytes were differentiated into macrophages in RPMI medium (Gibco, Grand Island, NY, USA) sup-
plemented with 10% FCS (Gibco) plus antibiotics and antimycotics (100 U/ml penicillin, 100 g/ml streptomycin, 
and 25 g/ml amphotericin; Gibco) in the presence of GM-CSF (50 ng/ml; R&D Systems, Minneapolis, MN, USA) 
for seven days.
Renal function outcomes. Urinary protein/creatinine ratios were measured in samples collected from the 
pelvis of obstructed mice 7 days post-surgery. All samples were analyzed through colorimetric assays using com-
mercially available kits for creatinine and protein measurement (Labtest, Minas Gerais, Brazil). Normalization 
was achieved by dividing the protein/creatinine ratio at day 7 by the ratio before surgery in each group of animals. 
Uric acid was measured in the kidney 7 days post-surgery (Labtest, Minas Gerais, Brazil). The results are pre-
sented as μ g uric acid/mg of total protein, which was measured using the Bradford assay (Bio-Rad, Hercules, CA).
Sirius red staining. Kidneys were harvested and placed in 10% buffered formaldehyde for fixation. In short, 
the slides were deparaffinized, rehydrated, and immersed in saturated picric acid solution for 15 minutes and 
then in Picrosirius for 20 minutes. Counterstaining was performed using Harris hematoxylin. Picrosirius-stained 
sections were analyzed using an Olympus BX50 microscope and camera. Manual photographs were taken of 
the renal cortex magnified at 40X and observed under polarized light. Images of at least 10 different fields in 
each slide were taken, and structures such as the glomeruli, sub capsular cortex, large vessels, and medulla were 
excluded. For the morphometric analysis, Java Image J software image processing and analysis were used. The 
results were represented as percentages and refer to the proportion of stained volume to total cortical interstitial 
volume.
Tissue hypoxia staining. To probe for kidney hypoxia, 60 mg/kg of pimonidazole (Chemicon, Temecula, 
CA) were injected intraperitoneally99. Staining was performed on paraffin sections using a microwave-based 
antigen retrieval technique. Sections were then incubated with the labeled polymer (Dual Link System-HRP, 
Glostrup, Denmark, DAKO). Staining was completed by incubating sections for 1 to 3 minutes with 
3,3-0-diaminobenzidine substrate-chromogen, which results in a brown-colored precipitate at the antigen site. 
Then hematoxylin counterstaining was performed. Images of at least 10 different fields in each slide were taken 
and the result of the analysis was represented as percentages and refers to the proportion of stained volume to 
total volume.
Transmission electron microscopy. Macrophages were fixed in PBS containing 4% PFA, 2% glutaralde-
hyde and 0.1 M cacodylate, pH 7.4 overnight at 4 °C. Samples were rinsed twice in PBS, and were postfixed in 1% 
osmium tetroxide (OsO4) for 2 hours. After that, cell pellets were placed in 0.5% uranile acetate in distilled water 
with sucrose 1% at 4 °C for 24 h. Cells were dehydrated in a series of alcoholic solutions from 70 to 100%, followed 
by two immersions in propylene oxide for 20 min each, propylene oxide and araldite infiltration for 12 h, at room 
temperature on a shaking platform. Subsequently, cells were incubated overnight in Spurr™ resin 1:1 mixed 
with 100% ethanol, before embedding in Spurr™ resin. Semithin sections were stained with toluidine blue and 
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examined in the light microscope. Ultrathin sections were double stained with 2% uranyl acetate and lead citrate. 
Observation was performed using a JEOL-JEM-100 CXII Transmission Electron Microscopy (TEM).
Quantitative real-time PCR. RT-PCR was performed using the Taqman real-time PCR assay (Applied 
Biosystem, USA) for the following molecules: Hprt (Mm00446968_m1), Il-1β (Mm00434228_m1), Myd88 
(Mm00440338_m1), Xdh (Mm00442110_m1), Il18 (Mm00434226_m1), Il-33 (Mm00505403_m1), Type 1 col-
lagen (Mm00801666_g1), inos (Mm00440502_m1) and Nlrp3 (Mm00840904_m1). Cycling conditions were as 
follows: 10 minutes at 95 °C, followed by 45 20 second cycles at 95 °C, 20 seconds at 58 °C, and 20 seconds at 72 °C. 
Analysis was performed using Sequence Detection Software 1.9 (SDS). mRNA expression was normalized to 
HPRT expression.
Hydroxyproline quantification. Hydroxyproline quantification was determined according to Reddy 
et al.100. Briefly, standard hydroxyproline (St. Louis, USA, Sigma) aliquots or kidney samples were hydrolyzed 
in sodium hydroxide (2 N final concentration). The hydrolyzed samples were then mixed with a buffered 
chloramine-T reagent, and oxidation was allowed to proceed for 25 minutes at room temperature. The chromo-
phore was then developed with the addition of Ehrlich’s reagent, and the absorbance of the reddish-purple 
complex was measured at 550 nm using a spectrophotometer. Absorbance values were plotted against the concen-
tration of standard hydroxyproline, and the presence of hydroxyproline was determined using the standard curve.
Cytokine profile. Total renal IL-1β protein from the culture supernatant were measured using IL-1β (R&D 
Systems, Minneapolis, MN, USA) Emax immunoassay systems (Promega, Madison, USA), according to the man-
ufacturer’s instructions.
Confocal imaging. Confocal Laser Scanning Microscopy (CLSM) was performed with a Leica TCS SP5 
SMD confocal system (Leica Microsystems). For live imaging, the temperature was maintained at 37 °C with 5% 
CO2 using an environmental control chamber (Life Imaging Services and Solent Scientific). Images were acquired 
using a 63X objective at time points noted in the figures or figure legends and analyzed using the LAS AF version 
2.2.1 (Leica Microsystems) or Volocity 6.01 software.
Glutathione levels. The concentrations of GSH and GSSG, as well as total glutathione, were determined 
using a colorimetric DTNB assay, as described in ref. 101. GSH reacts with DTNB producing TNB and GS-TNB, 
which is reduced back to GSH by GR. This process releases TNB, detected by absorbance at 412 nm.
Oxygen consumption rates. An hour before oxygen consumption measurements, cell media was replaced 
by assay media (2 mM glucose, 0.8 mM Mg2+, 1.8 mM Ca2+, 143 mM NaCl, 5.4 mM KCl, 0.91 mM NaH2PO4, and 
15 mg/mL Phenol red) for 60 min at 37 °C (no CO2) before loading into the Seahorse Bioscience XF96 extracellu-
lar analyzer102. During these 60 min, the ports of the cartridge containing the oxygen probes were loaded with the 
compounds to be injected during the assay (75 μ L/port) and the cartridge was calibrated. Basal respiration was 
recorded for 30 min, at 5 min intervals, until system stabilization. CCCP was used at final concentrations of 5 mM 
and injected with sodium pyruvate (Sigma) at a final concentration of 5 mM. Oligomycin and antimycin A were 
used at final concentrations of 1 and 10 μ g/mL, respectively. Rotenone was used at a concentration of 1 μ M. All 
respiratory modulators were used at ideal concentrations titrated during preliminary experiments (not shown). 
A typical OCR chart is displayed, where OCR represents the percentage of basal respiration.
Statistics. The data were described in terms of the mean and S.E.M. when three or more experiments were 
performed and S.D. when two different experiments were performed. Differences between groups were compared 
using ANOVA (with Tukey’s post-test) and Student’s t-test. Significant differences were regarded as p < 0.05. All 
statistical analyses were performed using GraphPad PRISM 6.01 (La Jolla, CA, USA).
References
1. So, A. & Thorens, B. Uric acid transport and disease. Journal of Clinical Investigation 120, 1791–1799, doi: 10.1172/jci42344 (2010).
2. Patschan, D., Patschan, S., Gobe, G. G., Chintala, S. & Goligorsky, M. S. Uric acid heralds ischemic tissue injury to mobilize 
endothelial progenitor cells. Journal of the American Society of Nephrology 18, 1516–1524, doi: 10.1681/asn.2006070759 (2007).
3. Shi, Y., Evans, J. E. & Rock, K. L. Molecular identification of a danger signal that alerts the immune system to dying cells. Nature 
425, 516–521, doi: 10.1038/nature01991 (2003).
4. Martinon, F., Petrilli, V., Mayor, A., Tardivel, A. & Tschopp, J. Gout-associated uric acid crystals activate the NALP3 inflammasome. 
Nature 440, 237–241, doi: 10.1038/nature04516 (2006).
5. Di Giovine, F. S., Malawista, S. E., Nuki, G. & Duff, G. W. Interleukin 1 (IL 1) as a mediator of crystal arthritis. Stimulation of T cell 
and synovial fibroblast mitogenesis by urate crystal-induced IL 1. J Immunol 138, 3213–3218 (1987).
6. Martinon, F., Burns, K. & Tschopp, J. The inflammasome: a molecular platform triggering activation of inflammatory caspases and 
processing of proIL-beta. Molecular cell 10, 417–426 (2002).
7. Hornung, V. et al. Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization. 
Nature immunology 9, 847–856, doi: 10.1038/ni.1631 (2008).
8. Duewell, P. et al. NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464, 
1357–1361, doi: 10.1038/nature08938 (2010).
9. Dostert, C. et al. Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica. Science 320, 674–677, doi: 
10.1126/science.1156995 (2008).
10. Franklin, B. S., Mangan, M. S. & Latz, E. Crystal Formation in Inflammation. Annual review of immunology 34, 173–202, doi: 
10.1146/annurev-immunol-041015-055539 (2016).
11. Lima, H. Jr. et al. Role of lysosome rupture in controlling Nlrp3 signaling and necrotic cell death. Cell Cycle 12, 1868–1878, doi: 
10.4161/cc.24903 (2013).
12. Schaefer, L. Complexity of danger: the diverse nature of damage-associated molecular patterns. The Journal of biological chemistry 
289, 35237–35245, doi: 10.1074/jbc.R114.619304 (2014).
www.nature.com/scientificreports/
1 2Scientific RepoRts | 7:39884 | DOI: 10.1038/srep39884
13. Crisan, T. O. et al. Soluble uric acid primes TLR-induced proinflammatory cytokine production by human primary cells via 
inhibition of IL-1Ra. Annals of the rheumatic diseases 75, 755–762, doi: 10.1136/annrheumdis-2014-206564 (2016).
14. Acauan Filho, B. J. et al. Serum nitrate and NOx levels in preeclampsia are higher than in normal pregnancy. Hypertension in 
pregnancy 35, 226–233, doi: 10.3109/10641955.2016.1139718 (2016).
15. Johnson, R. J., Lanaspa, M. A. & Gaucher, E. A. Uric acid: a danger signal from the RNA world that may have a role in the epidemic 
of obesity, metabolic syndrome, and cardiorenal disease: evolutionary considerations. Seminars in nephrology 31, 394–399, doi: 
10.1016/j.semnephrol.2011.08.002 (2011).
16. Cicerchi, C. et al. Uric acid-dependent inhibition of AMP kinase induces hepatic glucose production in diabetes and starvation: 
evolutionary implications of the uricase loss in hominids. FASEB journal: official publication of the Federation of American Societies 
for Experimental Biology 28, 3339–3350, doi: 10.1096/fj.13-243634 (2014).
17. Kratzer, J. T. et al. Evolutionary history and metabolic insights of ancient mammalian uricases. Proceedings of the National Academy 
of Sciences of the United States of America 111, 3763–3768, doi: 10.1073/pnas.1320393111 (2014).
18. Madero, M. et al. Uric Acid and Long-term Outcomes in CKD. American Journal of Kidney Diseases 53, 796–803, doi: 10.1053/j.
ajkd.2008.12.021 (2009).
19. Suliman, M. E. et al. J-shaped mortality relationship for uric acid in CKD. American Journal of Kidney Diseases 48, 761–771, doi: 
10.1053/j.ajkd.2006.08.019 (2006).
20. Gasse, P. et al. Uric Acid Is a Danger Signal Activating NALP3 Inflammasome in Lung Injury Inflammation and Fibrosis. American 
Journal of Respiratory and Critical Care Medicine 179, 903–913, doi: 10.1164/rccm.200808-1274OC (2009).
21. Martinon, F., Mayor, A. & Tschopp, J. The inflammasomes: guardians of the body. Annual review of immunology 27, 229–265, doi: 
10.1146/annurev.immunol.021908.132715 (2009).
22. Choi, J. S. & Ryter, S. W. Inflammasomes: Molecular Regulation and Implications for Metabolic and Cognitive Diseases. Molecules 
and cells, doi: 10.14348/molcells.2014.0104 (2014).
23. Martinon, F. & Tschopp, J. Inflammatory caspases: linking an intracellular innate immune system to autoinflammatory diseases. 
Cell 117, 561–574, doi: 10.1016/j.cell.2004.05.004 (2004).
24. Hoffman, H. M., Mueller, J. L., Broide, D. H., Wanderer, A. A. & Kolodner, R. D. Mutation of a new gene encoding a putative pyrin-
like protein causes familial cold autoinflammatory syndrome and Muckle-Wells syndrome. Nature genetics 29, 301–305, doi: 
10.1038/ng756 (2001).
25. Agostini, L. et al. NALP3 forms an IL-1beta-processing inflammasome with increased activity in Muckle-Wells autoinflammatory 
disorder. Immunity 20, 319–325 (2004).
26. Coll, R. C. et al. A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nature 
medicine 21, 248–255, doi: 10.1038/nm.3806 (2015).
27. Youm, Y. H. et al. The ketone metabolite beta-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease. 
Nature medicine 21, 263–269, doi: 10.1038/nm.3804 (2015).
28. Abderrazak, A. et al. NLRP3 inflammasome: from a danger signal sensor to a regulatory node of oxidative stress and inflammatory 
diseases. Redox biology 4, 296–307, doi: 10.1016/j.redox.2015.01.008 (2015).
29. Gurung, P., Lukens, J. R. & Kanneganti, T. D. Mitochondria: diversity in the regulation of the NLRP3 inflammasome. Trends in 
molecular medicine 21, 193–201, doi: 10.1016/j.molmed.2014.11.008 (2015).
30. Garaude, J. et al. Mitochondrial respiratory-chain adaptations in macrophages contribute to antibacterial host defense. Nature 
immunology, doi: 10.1038/ni.3509 (2016).
31. Freeman, L. C. & Ting, J. P. The pathogenic role of the inflammasome in neurodegenerative diseases. Journal of neurochemistry 136 
Suppl 1, 29–38, doi: 10.1111/jnc.13217 (2016).
32. Heneka, M. T., Kummer, M. P. & Latz, E. Innate immune activation in neurodegenerative disease. Nature reviews. Immunology 14, 
463–477, doi: 10.1038/nri3705 (2014).
33. Eisenbarth, S. C., Colegio, O. R., O’Connor, W., Sutterwala, F. S. & Flavell, R. A. Crucial role for the Nalp3 inflammasome in the 
immunostimulatory properties of aluminium adjuvants. Nature 453, 1122–1126, doi: 10.1038/nature06939 (2008).
34. Franklin, B. S., Mangan, M. S. & Latz, E. Crystal Formation in Inflammation. Annual review of immunology, doi: 10.1146/annurev-
immunol-041015-055539 (2016).
35. Ganeshan, K. & Chawla, A. Metabolic regulation of immune responses. Annual review of immunology 32, 609–634, doi: 10.1146/
annurev-immunol-032713-120236 (2014).
36. Figueira, T. R. et al. Mitochondria as a source of reactive oxygen and nitrogen species: from molecular mechanisms to human 
health. Antioxidants & redox signaling 18, 2029–2074, doi: 10.1089/ars.2012.4729 (2013).
37. Quinlan, C. L., Perevoshchikova, I. V., Hey-Mogensen, M., Orr, A. L. & Brand, M. D. Sites of reactive oxygen species generation by 
mitochondria oxidizing different substrates. Redox biology 1, 304–312, doi: 10.1016/j.redox.2013.04.005 (2013).
38. Sena, L. A. & Chandel, N. S. Physiological roles of mitochondrial reactive oxygen species. Molecular cell 48, 158–167, doi: 10.1016/j.
molcel.2012.09.025 (2012).
39. Shimada, K. et al. Oxidized mitochondrial DNA activates the NLRP3 inflammasome during apoptosis. Immunity 36, 401–414, doi: 
10.1016/j.immuni.2012.01.009 (2012).
40. Iyer, S. S. et al. Mitochondrial cardiolipin is required for Nlrp3 inflammasome activation. Immunity 39, 311–323, doi: 10.1016/j.
immuni.2013.08.001 (2013).
41. Murakami, T. et al. Critical role for calcium mobilization in activation of the NLRP3 inflammasome. Proceedings of the National 
Academy of Sciences of the United States of America 109, 11282–11287, doi: 10.1073/pnas.1117765109 (2012).
42. Weinberg, S. E., Sena, L. A. & Chandel, N. S. Mitochondria in the regulation of innate and adaptive immunity. Immunity 42, 
406–417, doi: 10.1016/j.immuni.2015.02.002 (2015).
43. Engerson, T. D. et al. Conversion of xanthine dehydrogenase to oxidase in ischemic rat-tissues. Journal of Clinical Investigation 79, 
1564–1570, doi: 10.1172/jci112990 (1987).
44. Lukens, J. R. et al. The NLRP12 Sensor Negatively Regulates Autoinflammatory Disease by Modulating Interleukin-4 Production 
in T Cells. Immunity 42, 654–664, doi: 10.1016/j.immuni.2015.03.006 (2015).
45. Cui, J. et al. NLRP4 negatively regulates type I interferon signaling by targeting the kinase TBK1 for degradation via the ubiquitin 
ligase DTX4. Nature immunology 13, 387–395, doi: 10.1038/ni.2239 (2012).
46. Kono, H., Chen, C. J., Ontiveros, F. & Rock, K. L. Uric acid promotes an acute inflammatory response to sterile cell death in mice. 
The Journal of clinical investigation 120, 1939–1949, doi: 10.1172/JCI40124 (2010).
47. Hooper, D. C. et al. Uric acid, a natural scavenger of peroxynitrite, in experimental allergic encephalomyelitis and multiple 
sclerosis. Proceedings of the National Academy of Sciences of the United States of America 95, 675–680 (1998).
48. Braga, T. T. et al. MyD88 signaling pathway is involved in renal fibrosis by favoring a TH2 immune response and activating 
alternative M2 macrophages. Mol Med 18, 1231–1239, doi: 10.2119/molmed.2012.00131 (2012).
49. Plank, M. S., Calderon, T. C., Asmerom, Y., Boskovic, D. S. & Angeles, D. M. Biochemical measurement of neonatal hypoxia. 
Journal of visualized experiments: JoVE, doi: 10.3791/2948 (2011).
50. Martin, A. C. & Brown, M. A. Could uric acid have a pathogenic role in pre-eclampsia? Nature reviews. Nephrology 6, 744–748, doi: 
10.1038/nrneph.2010.125 (2010).
51. Klahr, S. & Morrissey, J. Obstructive nephropathy and renal fibrosis. American journal of physiology. Renal physiology 283, 
F861–875, doi: 10.1152/ajprenal.00362.2001 (2002).
www.nature.com/scientificreports/
13Scientific RepoRts | 7:39884 | DOI: 10.1038/srep39884
52. Dendooven, A. et al. Oxidative stress in obstructive nephropathy. International journal of experimental pathology 92, 202–210, doi: 
10.1111/j.1365-2613.2010.00730.x (2011).
53. Julian, D., April, K. L., Patel, S., Stein, J. R. & Wohlgemuth, S. E. Mitochondrial depolarization following hydrogen sulfide exposure 
in erythrocytes from a sulfide-tolerant marine invertebrate. The Journal of experimental biology 208, 4109–4122, doi: 10.1242/
jeb.01867 (2005).
54. Pastore, A., Federici, G., Bertini, E. & Piemonte, F. Analysis of glutathione: implication in redox and detoxification. Clinica chimica 
acta; international journal of clinical chemistry 333, 19–39 (2003).
55. Zheng, Q. et al. Reactive oxygen species activated NLRP3 inflammasomes initiate inflammation in hyperosmolarity stressed 
human corneal epithelial cells and environment-induced dry eye patients. Experimental eye research 134, 133–140, doi: 10.1016/j.
exer.2015.02.013 (2015).
56. Jabir, M. S. et al. Mitochondrial damage contributes to Pseudomonas aeruginosa activation of the inflammasome and is 
downregulated by autophagy. Autophagy 11, 166–182, doi: 10.4161/15548627.2014.981915 (2015).
57. Liu, D. et al. Activation of the Nlrp3 inflammasome by mitochondrial reactive oxygen species: a novel mechanism of albumin-
induced tubulointerstitial inflammation. The international journal of biochemistry & cell biology 57, 7–19, doi: 10.1016/j.
biocel.2014.09.018 (2014).
58. Lupfer, C. & Kanneganti, T. D. Unsolved Mysteries in NLR Biology. Frontiers in immunology 4, 285, doi: 10.3389/fimmu.2013.00285 
(2013).
59. Gross, O., Thomas, C. J., Guarda, G. & Tschopp, J. The inflammasome: an integrated view. Immunological reviews 243, 136–151, 
doi: 10.1111/j.1600-065X.2011.01046.x (2011).
60. Forni, M. F., Chausse, B., Peloggia, J. & Kowaltowski, A. J. Bioenergetic profiling in the skin. Experimental dermatology 25, 147–148, 
doi: 10.1111/exd.12856 (2016).
61. Kevei, E. & Hoppe, T. Ubiquitin sets the timer: impacts on aging and longevity. Nature structural & molecular biology 21, 290–292, 
doi: 10.1038/nsmb.2806 (2014).
62. Segref, A. et al. Pathogenesis of human mitochondrial diseases is modulated by reduced activity of the ubiquitin/proteasome 
system. Cell metabolism 19, 642–652, doi: 10.1016/j.cmet.2014.01.016 (2014).
63. Infantino, V., Iacobazzi, V., Menga, A., Avantaggiati, M. L. & Palmieri, F. A key role of the mitochondrial citrate carrier (SLC25A1) 
in TNFalpha- and IFNgamma-triggered inflammation. Biochimica et biophysica acta 1839, 1217–1225, doi: 10.1016/j.
bbagrm.2014.07.013 (2014).
64. Lanaspa, M. A. et al. Uric acid induces hepatic steatosis by generation of mitochondrial oxidative stress: potential role in fructose-
dependent and -independent fatty liver. The Journal of biological chemistry 287, 40732–40744, doi: 10.1074/jbc.M112.399899 
(2012).
65. Wang, W. et al. Mitofusin-2 triggers mitochondria Ca2+ influx from the endoplasmic reticulum to induce apoptosis in 
hepatocellular carcinoma cells. Cancer letters 358, 47–58, doi: 10.1016/j.canlet.2014.12.025 (2015).
66. de Brito, O. M. & Scorrano, L. Mitofusin 2: a mitochondria-shaping protein with signaling roles beyond fusion. Antioxidants & 
redox signaling 10, 621–633, doi: 10.1089/ars.2007.1934 (2008).
67. Debattisti, V., Pendin, D., Ziviani, E., Daga, A. & Scorrano, L. Reduction of endoplasmic reticulum stress attenuates the defects 
caused by Drosophila mitofusin depletion. The Journal of cell biology 204, 303–312, doi: 10.1083/jcb.201306121 (2014).
68. Huang, H. et al. An interaction between Bcl-xL and the voltage-dependent anion channel (VDAC) promotes mitochondrial Ca2+ 
uptake. The Journal of biological chemistry 288, 19870–19881, doi: 10.1074/jbc.M112.448290 (2013).
69. Gatliff, J. et al. TSPO interacts with VDAC1 and triggers a ROS-mediated inhibition of mitochondrial quality control. Autophagy 
10, 2279–2296, doi: 10.4161/15548627.2014.991665 (2014).
70. Gatliff, J. & Campanella, M. TSPO is a REDOX regulator of cell mitophagy. Biochemical Society transactions 43, 543–552, doi: 
10.1042/BST20150037 (2015).
71. Gatliff, J. & Campanella, M. TSPO: kaleidoscopic 18-kDa amid biochemical pharmacology, control and targeting of mitochondria. 
The Biochemical journal 473, 107–121, doi: 10.1042/BJ20150899 (2016).
72. Messina, A., Reina, S., Guarino, F. & De Pinto, V. VDAC isoforms in mammals. Biochimica et biophysica acta 1818, 1466–1476, doi: 
10.1016/j.bbamem.2011.10.005 (2012).
73. Huang, H., Shah, K., Bradbury, N. A., Li, C. & White, C. Mcl-1 promotes lung cancer cell migration by directly interacting with 
VDAC to increase mitochondrial Ca2+ uptake and reactive oxygen species generation. Cell death & disease 5, e1482, doi: 10.1038/
cddis.2014.419 (2014).
74. Wolf, A. J. et al. Hexokinase Is an Innate Immune Receptor for the Detection of Bacterial Peptidoglycan. Cell, doi: 10.1016/j.
cell.2016.05.076 (2016).
75. Johnson, R. J., Andrews, P., Benner, S. A. & Oliver, W. Theodore E. Woodward award. The evolution of obesity: insights from the 
mid-Miocene. Transactions of the American Clinical and Climatological Association 121, 295–305, discussion 305–298 (2010).
76. Glantzounis, G. K., Tsimoyiannis, E. C., Kappas, A. M. & Galaris, D. A. Uric acid and oxidative stress. Current pharmaceutical 
design 11, 4145–4151 (2005).
77. Stocker, R. & Keaney, J. F. Jr. Role of oxidative modifications in atherosclerosis. Physiological reviews 84, 1381–1478, doi: 10.1152/
physrev.00047.2003 (2004).
78. Johnson, R. J. et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease? Hypertension 41, 
1183–1190, doi: 10.1161/01.HYP.0000069700.62727.C5 (2003).
79. Furukawa, S. et al. Increased oxidative stress in obesity and its impact on metabolic syndrome. The Journal of clinical investigation 
114, 1752–1761, doi: 10.1172/JCI21625 (2004).
80. Wellen, K. E. & Hotamisligil, G. S. Inflammation, stress, and diabetes. The Journal of clinical investigation 115, 1111–1119, doi: 
10.1172/JCI25102 (2005).
81. Sautin, Y. Y., Nakagawa, T., Zharikov, S. & Johnson, R. J. Adverse effects of the classic antioxidant uric acid in adipocytes: NADPH 
oxidase-mediated oxidative/nitrosative stress. American journal of physiology. Cell physiology 293, C584–596, doi: 10.1152/
ajpcell.00600.2006 (2007).
82. Gaudry, M. et al. Crystal-induced neutrophil activation. III. Inflammatory microcrystals induce a distinct pattern of tyrosine 
phosphorylation in human neutrophils. The Journal of clinical investigation 91, 1649–1655, doi: 10.1172/JCI116373 (1993).
83. Dai, H. et al. Combined Association of Serum Uric Acid and Metabolic Syndrome with Chronic Kidney Disease in Hypertensive 
Patients. Kidney & blood pressure research 41, 413–423, doi: 10.1159/000443443 (2016).
84. Bascands, J. L. & Schanstra, J. P. Obstructive nephropathy: Insights from genetically engineered animals. Kidney International 68, 
925–937, doi: 10.1111/j.1523-1755.2005.00486.x (2005).
85. Pulskens, W. P. et al. TLR4 Promotes Fibrosis but Attenuates Tubular Damage in Progressive Renal Injury. Journal of the American 
Society of Nephrology 21, 1299–1308, doi: 10.1681/asn.2009070722 (2010).
86. Leemans, J. C. et al. The Role of Toll-Like Receptor 2 in Inflammation and Fibrosis during Progressive Renal Injury. Plos One 4, doi: 
e5704 10.1371/journal.pone.0005704 (2009).
87. Xin, B.-m. et al. Activation of Toll-like receptor 9 attenuates unilateral ureteral obstruction-induced renal fibrosis. Acta 
Pharmacologica Sinica 31, 1583–1592, doi: 10.1038/aps.2010.202 (2010).
88. Paredes-Juarez, G. A. et al. DAMP production by human islets under low oxygen and nutrients in the presence or absence of an 
immunoisolating-capsule and necrostatin-1. Scientific reports 5, 14623, doi: 10.1038/srep14623 (2015).
www.nature.com/scientificreports/
1 4Scientific RepoRts | 7:39884 | DOI: 10.1038/srep39884
89. Beharrie, A. et al. A functional immature model of chronic partial ureteral obstruction. Kidney international 65, 1155–1161, doi: 
10.1111/j.1523-1755.2004.00488.x (2004).
90. Liu, C. F. et al. Rapamycin reduces renal hypoxia, interstitial inflammation and fibrosis in a rat model of unilateral ureteral 
obstruction. Clinical and investigative medicine. Medecine clinique et experimentale 37, E142 (2014).
91. Ludwig-Portugall, I. et al. An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice. Kidney 
international, doi: 10.1016/j.kint.2016.03.035 (2016).
92. Anders, H. J. & Schaefer, L. Beyond tissue injury-damage-associated molecular patterns, toll-like receptors, and inflammasomes 
also drive regeneration and fibrosis. Journal of the American Society of Nephrology: JASN 25, 1387–1400, doi: 10.1681/
ASN.2014010117 (2014).
93. Cruz, C. M. et al. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory 
cytokines in macrophages. The Journal of biological chemistry 282, 2871–2879, doi: 10.1074/jbc.M608083200 (2007).
94. Yang, Y. et al. Effect of uric acid on mitochondrial function and oxidative stress in hepatocytes. Genetics and molecular research: 
GMR 15, doi: 10.4238/gmr.15028644 (2016).
95. Dranka, B. P., Hill, B. G. & Darley-Usmar, V. M. Mitochondrial reserve capacity in endothelial cells: The impact of nitric oxide and 
reactive oxygen species. Free radical biology & medicine 48, 905–914, doi: 10.1016/j.freeradbiomed.2010.01.015 (2010).
96. Zhou, R., Yazdi, A. S., Menu, P. & Tschopp, J. A role for mitochondria in NLRP3 inflammasome activation. Nature 469, 221–225, 
doi: 10.1038/nature09663 (2011).
97. da-Silva, W. S. et al. Mitochondrial bound hexokinase activity as a preventive antioxidant defense: steady-state ADP formation as 
a regulatory mechanism of membrane potential and reactive oxygen species generation in mitochondria. The Journal of biological 
chemistry 279, 39846–39855, doi: 10.1074/jbc.M403835200 (2004).
98. Stutz, A., Horvath, G. L., Monks, B. G. & Latz, E. ASC speck formation as a readout for inflammasome activation. Methods Mol Biol 
1040, 91–101, doi: 10.1007/978-1-62703-523-1_8 (2013).
99. Imamura, R. et al. Erythropoietin protects the kidneys against ischemia reperfusion injury by activating hypoxia inducible factor-1 
alpha. Transplantation 83, 1371–1379, doi: 10.1097/01.tp.0000264200.38926.70 (2007).
100. Reddy, G. K. & Enwemeka, C. S. A simplified method for the analysis of hydroxyproline in biological tissues. Clinical biochemistry 
29, 225–229 (1996).
101. Rahman, I., Kode, A. & Biswas, S. K. Assay for quantitative determination of glutathione and glutathione disulfide levels using 
enzymatic recycling method. Nature protocols 1, 3159–3165, doi: 10.1038/nprot.2006.378 (2006).
102. Wu, M. et al. Multiparameter metabolic analysis reveals a close link between attenuated mitochondrial bioenergetic function and 
enhanced glycolysis dependency in human tumor cells. American journal of physiology. Cell physiology 292, C125–136, doi: 
10.1152/ajpcell.00247.2006 (2007).
Acknowledgements
We would like to thank Professor Vera Calich, from the University of Sao Paulo-SP, for providing NLRP3−/− mice; 
Professor Joao Santana Silva, from University of Sao Paulo-RP, for providing Casp-1−/− and IL1R−/− mice; and 
Professor William Festuccia, from University of Sao Paulo-SP, for providing LyzCre mice. This research received 
funding from CNPq (Fluid Complex INCT) and Sao Paulo Research Foundation (Fapesp) under grant agreement 
nos 2014/06992-8, 2012/02270-2 and 2013/07937-8.
Author Contributions
T.T.B. designed and performed the experiments, analyzed data and wrote the paper. B.S.F., A.J.K. and N.O.S.C. 
supervised the project. M.F.F., M.C.C., R.N.R., P.B., A.C., M.I.H. and M.R.D. performed experiments and 
analyzed data. J.A.B. supervised the project. All authors have revised the manuscript critically for important 
intellectual content.
Additional Information
Supplementary information accompanies this paper at http://www.nature.com/srep
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Braga, T. T. et al. Soluble Uric Acid Activates the NLRP3 Inflammasome. Sci. Rep. 7, 
39884; doi: 10.1038/srep39884 (2017).
Publisher's note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and 
institutional affiliations.
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
 
© The Author(s) 2017
